Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024
Bristol Myers Squibb (NYSE: BMY) has announced that it will release its third quarter 2024 financial results on Thursday, October 31, 2024. The company will host a conference call and live webcast at 8:00 a.m. ET on the same day to discuss the results and address questions from investors and analysts. Interested parties can listen to the webcast at http://investor.bms.com or register for the live call. A replay of the webcast and conference call will be available until November 14, 2024. This announcement provides investors and analysts with an opportunity to gain insights into BMY's financial performance and future outlook.
Bristol Myers Squibb (NYSE: BMY) ha annunciato che rilascerà i suoi risultati finanziari per il terzo trimestre del 2024 giovedì 31 ottobre 2024. L'azienda ospiterà una conferenza telefonica e una webcasting dal vivo alle 8:00 ET dello stesso giorno per discutere i risultati e rispondere alle domande di investitori e analisti. Le parti interessate possono ascoltare la webcasting su http://investor.bms.com o registrarsi per la chiamata dal vivo. Una registrazione della webcasting e della conferenza telefonica sarà disponibile fino al 14 novembre 2024. Questo annuncio offre agli investitori e agli analisti l'opportunità di ottenere informazioni sulle performance finanziarie di BMY e sulle prospettive future.
Bristol Myers Squibb (NYSE: BMY) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el jueves 31 de octubre de 2024. La empresa llevará a cabo una llamada en conferencia y una retransmisión en vivo a las 8:00 a.m. ET el mismo día para discutir los resultados y responder preguntas de inversores y analistas. Las partes interesadas pueden escuchar la retransmisión en http://investor.bms.com o registrarse para la llamada en vivo. Una repetición de la retransmisión y la llamada en conferencia estará disponible hasta el 14 de noviembre de 2024. Este anuncio proporciona a inversores y analistas la oportunidad de obtener información sobre el desempeño financiero de BMY y sus perspectivas futuras.
Bristol Myers Squibb (NYSE: BMY)는 2024년 3분기 재무 결과를 2024년 10월 31일 목요일에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8:00 ET에 결과를 논의하고 투자자 및 분석가의 질문에 답하기 위해 컨퍼런스 콜과 라이브 웹캐스트를 진행합니다. 관심 있는 분들은 http://investor.bms.com에서 웹캐스트를 들으실 수 있고, 라이브 콜에 등록할 수 있습니다. 웹캐스트와 컨퍼런스 콜의 재생은 2024년 11월 14일까지 가능할 것입니다. 이 발표는 투자자와 분석가에게 BMY의 재무 성과와 향후 전망에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
Bristol Myers Squibb (NYSE: BMY) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le jeudi 31 octobre 2024. L'entreprise organisera une conférence téléphonique et un webinaire en direct à 8h00 ET le même jour pour discuter des résultats et répondre aux questions des investisseurs et des analystes. Les parties intéressées peuvent écouter le webinaire à l'adresse http://investor.bms.com ou s'inscrire pour l'appel en direct. Un replay du webinaire et de la conférence téléphonique sera disponible jusqu'au 14 novembre 2024. Cette annonce offre aux investisseurs et aux analystes l'opportunité d'obtenir des informations sur la performance financière de BMY et ses perspectives futures.
Bristol Myers Squibb (NYSE: BMY) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 am Donnerstag, den 31. Oktober 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz und ein Live-Webcast abhalten, um die Ergebnisse zu besprechen und Fragen von Investoren und Analysten zu beantworten. Interessierte Parteien können das Webcast unter http://investor.bms.com hören oder sich für den Live-Call registrieren. Eine Wiederholung des Webcasts und der Telefonkonferenz wird bis zum 14. November 2024 verfügbar sein. Diese Ankündigung bietet Investoren und Analysten die Möglichkeit, Einblicke in die finanzielle Leistung von BMY und die zukünftigen Perspektiven zu gewinnen.
- None.
- None.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Investors and the public can register for the live conference call here. Those unable to register can access the live conference call by dialing in the
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on October 31, 2024, through 11:30 a.m. ET on November 14, 2024, by dialing in the
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20240912717463/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When will Bristol Myers Squibb (BMY) report its Q3 2024 earnings?
What time is Bristol Myers Squibb's (BMY) Q3 2024 earnings call?
How can I listen to Bristol Myers Squibb's (BMY) Q3 2024 earnings call?
Until when will the replay of Bristol Myers Squibb's (BMY) Q3 2024 earnings call be available?
